32,734 Shares in Medifast, Inc. (NYSE:MED) Purchased by Landscape Capital Management L.L.C.

Landscape Capital Management L.L.C. bought a new stake in shares of Medifast, Inc. (NYSE:MED - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 32,734 shares of the specialty retailer's stock, valued at approximately $577,000. Landscape Capital Management L.L.C. owned 0.30% of Medifast as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. JPMorgan Chase & Co. raised its holdings in shares of Medifast by 156.1% during the third quarter. JPMorgan Chase & Co. now owns 57,455 shares of the specialty retailer's stock valued at $1,100,000 after purchasing an additional 35,017 shares during the period. Amundi acquired a new position in Medifast during the 4th quarter worth approximately $374,000. American Century Companies Inc. raised its stake in Medifast by 3.4% during the 4th quarter. American Century Companies Inc. now owns 244,185 shares of the specialty retailer's stock worth $4,303,000 after buying an additional 8,058 shares during the period. Centiva Capital LP boosted its holdings in Medifast by 6.3% in the third quarter. Centiva Capital LP now owns 15,238 shares of the specialty retailer's stock worth $292,000 after acquiring an additional 898 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its holdings in shares of Medifast by 2,308.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 11,442 shares of the specialty retailer's stock valued at $202,000 after acquiring an additional 10,967 shares in the last quarter. 95.51% of the stock is owned by institutional investors.

Medifast Price Performance

Shares of NYSE:MED traded down $0.43 during midday trading on Friday, hitting $12.71. 44,826 shares of the company's stock were exchanged, compared to its average volume of 324,415. Medifast, Inc. has a 12 month low of $12.30 and a 12 month high of $36.30. The company has a market cap of $139.04 million, a PE ratio of 70.61 and a beta of 1.05. The stock has a 50 day moving average price of $14.27 and a 200-day moving average price of $16.64.

Medifast (NYSE:MED - Get Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The specialty retailer reported $0.10 EPS for the quarter, topping analysts' consensus estimates of ($0.16) by $0.26. Medifast had a return on equity of 10.64% and a net margin of 0.35%. The firm had revenue of $119.00 million during the quarter, compared to analyst estimates of $114.25 million. On average, analysts anticipate that Medifast, Inc. will post 0.51 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, DA Davidson cut their target price on Medifast from $17.00 to $16.50 and set a "neutral" rating on the stock in a report on Wednesday, February 19th.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.